Provided by Tiger Fintech (Singapore) Pte. Ltd.

GlucoTrack, Inc.

0.1400
-0.0092-6.17%
Pre-market: 0.14000.00000.00%05:14 EDT
Volume:2.00M
Turnover:285.69K
Market Cap:4.01M
PE:0.00
High:0.1476
Open:0.1447
Low:0.1380
Close:0.1492
Loading ...

GlucoTrack Inc. Q1 2025 Results: Cash Position Increases to $9.1 Million, Driven by $6.4 Million from Financing Activities

Reuters
·
15 May

GlucoTrack Q1 EPS $(0.67) Up From $(11.73) YoY

Benzinga
·
15 May

BRIEF-Glucotrack Reports First Quarter 2025 Financial Results And Recent Corporate Highlights

Reuters
·
15 May

GlucoTrack Inc - FDA Ide Approval for GlucoTrack Cbgm Expected in Q4 2025

THOMSON REUTERS
·
15 May

GlucoTrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

THOMSON REUTERS
·
15 May

GlucoTrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor

THOMSON REUTERS
·
13 May

GlucoTrack Inc. Secures Ethical Approval for Long-Term Clinical Study of Innovative Continuous Blood Glucose Monitor

Reuters
·
13 May

GlucoTrack Inc. Announces Virtual Annual Meeting of Stockholders

Reuters
·
28 Apr

Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas

GlobeNewswire
·
16 Apr

BRIEF-Glucotrack And Onetwo Analytics To Collaborate For Clinical Study Analysis On Its Continuous Blood Glucose Monitor

Reuters
·
03 Apr

GlucoTrack, OneTwo Analytics collaborate to study analysis on CBG Monitor

TIPRANKS
·
03 Apr

GlucoTrack and Onetwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor

THOMSON REUTERS
·
03 Apr

Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor

GlobeNewswire
·
03 Apr

Glucotrack 2024 EPS $(68.44) Down From $(34.18) YoY

Benzinga
·
01 Apr

Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire
·
01 Apr

Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes

GlobeNewswire
·
19 Mar

Glucotrack appoints Umpierrez to Medical Advisory Board

TIPRANKS
·
26 Feb

GlucoTrack Appoints Guillermo Umpierrez, Md, Cdces, Face, Macp as New Medical Advisory Board Member

THOMSON REUTERS
·
26 Feb

Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member

GlobeNewswire
·
26 Feb

Glucotrack Prices $3 Million Public Offering to Fund Expansion

GuruFocus.com
·
06 Feb